Melatonin May Curtail the Metabolic Syndrome: Studies on Initial and Fully Established Fructose-Induced Metabolic Syndrome in Rats
暂无分享,去创建一个
[1] E. D. du Toit,et al. Melatonin and the metabolic syndrome: a tool for effective therapy in obesity‐associated abnormalities? , 2012, Acta physiologica.
[2] K. Ohashi,et al. Melatonin improves metabolic syndrome induced by high fructose intake in rats , 2012, Journal of pineal research.
[3] B. Cummings,et al. Fructose‐Fed Rhesus Monkeys: A Nonhuman Primate Model of Insulin Resistance, Metabolic Syndrome, and Type 2 Diabetes , 2011, Clinical and translational science.
[4] L. Fuentes-Broto,et al. Significance and application of melatonin in the regulation of brown adipose tissue metabolism: relation to human obesity , 2011, Obesity reviews : an official journal of the International Association for the Study of Obesity.
[5] D. Cardinali,et al. Melatonin—A pleiotropic, orchestrating regulator molecule , 2011, Progress in Neurobiology.
[6] D. Cardinali,et al. Melatonin and the Metabolic Syndrome: Physiopathologic and Therapeutical Implications , 2011, Neuroendocrinology.
[7] D. Cardinali,et al. Melatonin effect on plasma adiponectin, leptin, insulin, glucose, triglycerides and cholesterol in normal and high fat–fed rats , 2010, Journal of pineal research.
[8] L. Tappy,et al. Fructose and metabolic diseases: new findings, new questions. , 2010, Nutrition.
[9] D. Dijk,et al. British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders , 2010, Journal of psychopharmacology.
[10] G. Oxenkrug,et al. Ramelteon attenuates age‐associated hypertension and weight gain in spontaneously hypertensive rats , 2010, Annals of the New York Academy of Sciences.
[11] Kathryn Moynihan Ramsey,et al. Circadian Rhythms and Metabolic Syndrome: From Experimental Genetics to Human Disease , 2010, Circulation research.
[12] C. Sartori,et al. Melatonin improves glucose homeostasis and endothelial vascular function in high-fat diet-fed insulin-resistant mice. , 2009, Endocrinology.
[13] A. Avenell,et al. Systematic Review of Long-term Lifestyle Interventions to Prevent Weight Gain and Morbidity in Adults. Authors: , 2009 .
[14] J. McNeill,et al. The fructose-fed rat: a review on the mechanisms of fructose-induced insulin resistance and hypertension , 2009, Molecular and Cellular Biochemistry.
[15] Zhenyu Guo,et al. NEU-P11, a novel melatonin agonist, inhibits weight gain and improves insulin sensitivity in high-fat/high-sucrose-fed rats. , 2009, Pharmacological research.
[16] Marta Garaulet,et al. Chronobiology, genetics and metabolic syndrome , 2009, Current opinion in lipidology.
[17] F. Scheer,et al. Adverse metabolic and cardiovascular consequences of circadian misalignment , 2009, Proceedings of the National Academy of Sciences.
[18] E. Grossman,et al. The role of melatonin in the pathogenesis of hypertension in rats with metabolic syndrome. , 2008, American journal of hypertension.
[19] Nihal Ahmad,et al. Dose translation from animal to human studies revisited , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[20] C. Alonso-González,et al. Melatonin and estradiol effects on food intake, body weight, and leptin in ovariectomized rats. , 2007, Maturitas.
[21] H. Dralle,et al. Melatonin and type 2 diabetes – a possible link? * , 2007, Journal of pineal research.
[22] M. Raskind,et al. Olanzapine-Induced Weight Gain and Increased Visceral Adiposity is Blocked by Melatonin Replacement Therapy in Rats , 2007, Neuropsychopharmacology.
[23] Marwa A. Ahmed,et al. Intake of melatonin is associated with amelioration of physiological changes, both metabolic and morphological pathologies associated with obesity: an animal model , 2006, International journal of experimental pathology.
[24] D. Rasmussen,et al. Melatonin effect on rat body weight regulation in response to high-fat diet at middle age , 2003, Endocrine.
[25] B. Guardiola-Lemaitre. Agonistes et antagonistes des récepteurs mélatoninergiques : perspectives thérapeutiques , 2007 .
[26] B. Guardiola‐Lemaître. [Melatoninergic receptor agonists and antagonists: therapeutic perspectives]. , 2007, Journal de la Societe de biologie.
[27] Y. Sharabi,et al. Melatonin reduces night blood pressure in patients with nocturnal hypertension. , 2006, The American journal of medicine.
[28] Takahiko Nakagawa,et al. A causal role for uric acid in fructose-induced metabolic syndrome. , 2006, American journal of physiology. Renal physiology.
[29] K. Shimamoto,et al. Mechanisms of Insulin Resistance in Hypertensive Rats , 2006, Clinical and experimental hypertension.
[30] M. Kanter,et al. Depression of glucose levels and partial restoration of pancreatic β-cell damage by melatonin in streptozotocin-induced diabetic rats , 2006, Archives of Toxicology.
[31] A. Cagnacci,et al. Prolonged melatonin administration decreases nocturnal blood pressure in women. , 2005, American journal of hypertension.
[32] S. Daniels,et al. Blood pressure‐lowering effect of melatonin in type 1 diabetes , 2004, Journal of pineal research.
[33] F. Scheer,et al. Daily Nighttime Melatonin Reduces Blood Pressure in Male Patients With Essential Hypertension , 2004, Hypertension.
[34] P. Renard,et al. Melatonin reduces body weight gain in Sprague Dawley rats with diet-induced obesity. , 2003, Endocrinology.
[35] R. Sato,et al. Effect of pinealectomy on plasma levels of insulin and leptin and on hepatic lipids in type 2 diabetic rats , 2003, Journal of pineal research.
[36] D. Cardinali,et al. Melatonin increases oestradiol‐induced bone formation in ovariectomized rats , 2003, Journal of pineal research.
[37] N. Roglans,et al. Atorvastatin treatment induced peroxisome proliferator-activated receptor alpha expression and decreased plasma nonesterified fatty acids and liver triglyceride in fructose-fed rats. , 2002, The Journal of pharmacology and experimental therapeutics.
[38] C. K. Song,et al. Seasonal Changes in Adiposity: the Roles of the Photoperiod, Melatonin and Other Hormones, and Sympathetic Nervous System , 2002, Experimental biology and medicine.
[39] S. Nakagawa,et al. Long‐term melatonin administration reduces hyperinsulinemia and improves the altered fatty‐acid compositions in type 2 diabetic rats via the restoration of Δ‐5 desaturase activity , 2002, Journal of pineal research.
[40] G. Lewis,et al. Chronic exogenous insulin and chronic carbohydrate supplementation increase de novo VLDL triglyceride fatty acid production in rats. , 1997, Journal of lipid research.
[41] J. McNeill,et al. Fructose-induced hypertension in rats is concentration- and duration-dependent. , 1995, Journal of pharmacological and toxicological methods.